Nurix Therapeutics Inc’s recent filing unveils that its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $0.23 million on Sep 03 ’24. In the deal valued at $24.94 per share,9,050 shares were sold. As a result of this transaction, Ring Christine now holds 24,592 shares worth roughly $0.55 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, CHRISTINE RING bought 9,050 shares, generating $228,060 in total proceeds.
Before that, Ring Christine sold 9,870 shares. Nurix Therapeutics Inc shares valued at $246,843 were divested by the Chief Legal Officer at a price of $25.01 per share. As a result of the transaction, Ring Christine now holds 24,592 shares, worth roughly $0.55 million.
A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Barclays started covering the stock on March 09, 2023. It rated NRIX as “an Overweight”.
Price Performance Review of NRIX
On Monday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -2.52% to $22.47. Over the last five days, the stock has lost -6.76%. Nurix Therapeutics Inc shares have risen nearly 117.73% since the year began. Nevertheless, the stocks have risen 176.04% over the past one year. While a 52-week high of $26.31 was reached on 09/18/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $23.09, while 200 days put it at $16.01.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 21.74, which if violated will result in even more drops to 21.00. On the upside, there is a resistance level at 23.60. A further resistance level may holdings at 24.73. The Relative Strength Index (RSI) on the 14-day chart is 40.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.98%. Stochastics %K at 7.17% indicates the stock is a buying.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-09-13, growing by 0.13 million shares to a total of 9.36 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 9.24 million shares. There was a rise of 1.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 28, 2023 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
